Stay updated on LN-144 in Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the LN-144 in Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the LN-144 in Metastatic Uveal Melanoma Clinical Trial page
- Check4 days agoChange DetectedBroadens eligibility by removing the 3-year prior malignancy exclusion and adds an explicit ban on active concurrent malignancies requiring systemic treatment, with an exception for adjuvant NED cancers on hormone therapy (Revision: v3.0.2, dated 2025-09-11/12).SummaryDifference6%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check19 days agoChange DetectedThe web page has been updated to include new drug information for Lifileucel and resources related to Uveal Melanoma, while several previous entries related to various types of sarcomas and other neoplasms have been removed.SummaryDifference3%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
Stay in the know with updates to LN-144 in Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-144 in Metastatic Uveal Melanoma Clinical Trial page.